Remove FDA Remove Governance Remove Presentation Remove Public Health
article thumbnail

Public Health Product Hops

Bill of Health

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. But perhaps other forms of public health benefit would outweigh these harms?

article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. public investment in the development of mRNA COVID-19 vaccines between 1985 to 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Supreme Court Threatens to Undermine Vaccination Decisions Entrusted to the States

Bill of Health

Newsom a legal principle that threatens to upend over a century of legal precedent recognizing the authority of state governments to ensure public health by mandating vaccines. Presently, among the fifty U.S. In 2021, the Supreme Court articulated in Tandon v.

COVID-19 157
article thumbnail

Maximizing Healthcare Data Starts with a Human-Centric Approach

Healthcare IT Today

The following is a guest article by Chris Anello, Director of Digital Platforms at iTech AG The COVID-19 pandemic pushed healthcare organizations to the edge and exposed both challenges and opportunities related to public health data. This is one area where CX can come in.

COVID-19 109
article thumbnail

AI’s Ability to Manipulate Decision Making Requires a Moratorium on Its Use in Obtaining Consent for Biomedical Research

Bill of Health

The federal government’s commitment to assuring that participants in human subject research provide fully informed consent dates back to the U.S But ethics review boards, often called IRBs are already required to pre-approve all materials used to advertise studies, as well as those presented directly to potential participants.

article thumbnail

 Are Hospitals Ready for Alzheimer’s Treatment Approval?

HIT Consultant

However, few health systems, medical practices, or providers are prepared for the extraordinary public interest in a treatment for Alzheimer’s disease – especially not one targeting mild cognitive impairment (MCI) and early dementia due to Alzheimer’s disease – that is likely headed their way soon. billion marketing the medication.

article thumbnail

Psychedelic Inequities and Unexplored Risk: Colonization, Commercialization, and Regulation

Bill of Health

There is a common and problematic misconception that colonization was an isolated historical event and that the present is somehow divorced from its precedent. To explore how colonization drives health inequities, we have to acknowledge the causal relationship between what is past and what is present and think critically about colonization.